166 related articles for article (PubMed ID: 34525396)
1. The mitochondria-targeting antioxidant MitoQ alleviated lipopolysaccharide/ d-galactosamine-induced acute liver injury in mice.
Hu K; Xiao L; Li L; Shen Y; Yang Y; Huang J; Wang Y; Zhang L; Wen S; Tang L
Immunol Lett; 2021 Dec; 240():24-30. PubMed ID: 34525396
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway.
Peng X; Yang Y; Tang L; Wan J; Dai J; Li L; Huang J; Shen Y; Lin L; Gong X; Zhang L
Biomed Pharmacother; 2020 May; 125():110020. PubMed ID: 32106375
[TBL] [Abstract][Full Text] [Related]
3. Herbal formula CGX ameliorates LPS/D-galactosamine-induced hepatitis.
Shin JW; Wang JH; Park HJ; Choi MK; Kim HG; Son CG
Food Chem Toxicol; 2011 Jun; 49(6):1329-34. PubMed ID: 21414374
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion
Gan L; Wang Z; Si J; Zhou R; Sun C; Liu Y; Ye Y; Zhang Y; Liu Z; Zhang H
Toxicol Appl Pharmacol; 2018 Feb; 341():1-7. PubMed ID: 29317239
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant mitoquinone ameliorates EtOH-LPS induced lung injury by inhibiting mitophagy and NLRP3 inflammasome activation.
Sang W; Chen S; Lin L; Wang N; Kong X; Ye J
Front Immunol; 2022; 13():973108. PubMed ID: 36059543
[TBL] [Abstract][Full Text] [Related]
6. Sleep deprivation aggravated lipopolysaccharide/D-galactosamine-induced acute liver injury by suppressing melatonin production.
Liu L; Zhang L; Li L; Chen M; Wang Z; Shen Y; Huang J; Tang L
Inflamm Res; 2020 Nov; 69(11):1133-1142. PubMed ID: 32809047
[TBL] [Abstract][Full Text] [Related]
7. Rotenone, a mitochondrial respiratory complex I inhibitor, ameliorates lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice.
Ai Q; Jing Y; Jiang R; Lin L; Dai J; Che Q; Zhou D; Jia M; Wan J; Zhang L
Int Immunopharmacol; 2014 Jul; 21(1):200-7. PubMed ID: 24830863
[TBL] [Abstract][Full Text] [Related]
8. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
[TBL] [Abstract][Full Text] [Related]
9. Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice.
Liu A; Shen Y; Du Y; Chen J; Pei F; Fu W; Qiao J
Microb Pathog; 2018 Dec; 125():418-422. PubMed ID: 30290266
[TBL] [Abstract][Full Text] [Related]
10. Caloric restriction mimetic 2-deoxyglucose alleviated lethal liver injury induced by lipopolysaccharide/D-galactosamine in mice.
Che Q; Lin L; Ai Q; Ge P; Dai J; Jiang R; Zhou D; Wan J; Zhang L
Biochem Biophys Res Commun; 2015 Apr; 459(3):541-6. PubMed ID: 25749337
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of garcinol in mice with lipopolysaccharide/D-galactosamine-induced apoptotic liver injury.
Jing Y; Ai Q; Lin L; Dai J; Jia M; Zhou D; Che Q; Wan J; Jiang R; Zhang L
Int Immunopharmacol; 2014 Apr; 19(2):373-80. PubMed ID: 24560905
[TBL] [Abstract][Full Text] [Related]
12. MitoQ protects against carbon tetrachloride-induced hepatocyte ferroptosis and acute liver injury by suppressing mtROS-mediated ACSL4 upregulation.
Tao L; Xue YF; Sun FF; He X; Wang HQ; Tong CC; Zhang C; Xu DX; Chen X
Toxicol Appl Pharmacol; 2024 May; 486():116914. PubMed ID: 38522585
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
Yang C; He L; Wang C; Huang Y; Wang A; Li X; Ao J
Int Immunopharmacol; 2019 Jul; 72():367-373. PubMed ID: 31030092
[TBL] [Abstract][Full Text] [Related]
14. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis.
Lowes DA; Thottakam BM; Webster NR; Murphy MP; Galley HF
Free Radic Biol Med; 2008 Dec; 45(11):1559-65. PubMed ID: 18845241
[TBL] [Abstract][Full Text] [Related]
15. Panaxynol from
Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
[TBL] [Abstract][Full Text] [Related]
16. Lysine specific demethylase 1 inhibitor alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury.
Wang X; Sun Y; Fu Y; Wu H; Chen Y; Ye Y; Zhou Q; He L; Zhou E; Wang J; Yang Z
Eur J Pharmacol; 2022 Oct; 932():175227. PubMed ID: 36007605
[TBL] [Abstract][Full Text] [Related]
17. Lycopene Prevents Mitochondrial Dysfunction during d-Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure in Albino Rats.
Sheriff SA; Shaik Ibrahim S; Devaki T; Chakraborty S; Agarwal S; Pérez-Sánchez H
J Proteome Res; 2017 Sep; 16(9):3190-3199. PubMed ID: 28758404
[TBL] [Abstract][Full Text] [Related]
18. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.
Xiao L; Xu X; Zhang F; Wang M; Xu Y; Tang D; Wang J; Qin Y; Liu Y; Tang C; He L; Greka A; Zhou Z; Liu F; Dong Z; Sun L
Redox Biol; 2017 Apr; 11():297-311. PubMed ID: 28033563
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
Dashdorj A; Jyothi KR; Lim S; Jo A; Nguyen MN; Ha J; Yoon KS; Kim HJ; Park JH; Murphy MP; Kim SS
BMC Med; 2013 Aug; 11():178. PubMed ID: 23915129
[TBL] [Abstract][Full Text] [Related]
20. Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
Hu JJ; Wang H; Pan CW; Lin MX
Microb Pathog; 2018 Jun; 119():86-92. PubMed ID: 29604422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
